Terms: = Ovarian cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Clinical Outcome
3 results:
1. Genetic variants as ovarian cancer first-line treatment hallmarks: A systematic review and meta-analysis.
Assis J; Pereira C; Nogueira A; Pereira D; Carreira R; Medeiros R
Cancer Treat Rev; 2017 Dec; 61():35-52. PubMed ID: 29100168
[TBL] [Abstract] [Full Text] [Related]
2. Genome-wide DNA copy number analysis in clonally expanded human ovarian cancer cells with distinct invasive/migratory capacities.
Li L; Bai H; Yang J; Cao D; Shen K
Oncotarget; 2017 Feb; 8(9):15136-15148. PubMed ID: 28122348
[TBL] [Abstract] [Full Text] [Related]
3. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
Kang S; Sun HY; Zhou RM; Wang N; Hu P; Li Y
Asian Pac J Cancer Prev; 2013; 14(2):941-6. PubMed ID: 23621265
[TBL] [Abstract] [Full Text] [Related]
